Vol 3, No 2 (June 30, 2014): Chinese Clinical Oncology (The Changing World of Drug Development - Guest Editor: Christian Dittrich)

Editorial

The changing world of drug development

Christian Dittrich

PDF Pages: 12 Full Text (5060) Open Access

Review Article

The spectrum of clinical trials aiming at personalizing medicine

Christophe Le Tourneau, Maud Kamal, Marie Alt, Loic Verlingue, Vincent Servois, Marie-Paule Sablin, Nicolas Servant, Xavier Paoletti

PDF Pages: 13 Full Text (10568) Open Access

Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicine

Sumithra J. Mandrekar, Daniel J. Sargent

PDF Pages: 14 Full Text (11268) Open Access

Integrative oncology drug discovery accompanied by preclinical translational research as prerequisite for clinical development

Jens Hoffmann

PDF Pages: 15 Full Text (9490) Open Access

From genomic data analysis to drug development: a new generation of trials using molecular marker assessment in breast cancer

Sophie Doisneau-Sixou, Nadia Harbeck

PDF Pages: 16 Full Text (11416) Open Access

Functional and molecular imaging in cancer drug development

Vikram Rao Bollineni, Sandra Collette, Yan Liu

PDF Pages: 17 Full Text (8338) Open Access

New challenge of developing combined radio-drug therapy

Philippe Maingon, Anne-Sophie Govaerts, Sofia Rivera, Conchita Vens, Emad Shash, Vincent Grégoire

PDF Pages: 18 Full Text (5891) Open Access

The changing world of drug development: an academic research organization’s perspective on the “Seven Wonders” of the future world of anticancer drug development

Yan Liu, Denis Lacombe, Roger Stupp

PDF Pages: 19 Full Text (7008) Open Access

The changing world of oncology drug development—A global pharmaceutical company’s perspective

Susan Galbraith

PDF Pages: 20 Full Text (8560) Open Access

Medicine adaptive pathways to patients (MAPPs): using regulatory innovation to defeat Eroom’s law

Duane Schulthess, Magda Chlebus, Richard Bergstrӧm, Karin Van Baelen

PDF Pages: 21 Full Text (7006) Open Access

The changing world of cancer drug development: the regulatory bodies’ perspective

Iordanis Gravanis, Camille Vleminckx, Bertil Jonsson, Francesco Pignatti

PDF Pages: 22 Full Text (7451) Open Access

The positioning of economic principles under the changing conditions of the novel drug developmental process in cancer

Nils Wilking, Ulla Wilking, Bengt Jönsson

PDF Pages: 23 Full Text (8182) Open Access

And now for something completely different: drugs that work!—The patients’ perspective

Peter Kapitein

PDF Pages: 24 Full Text (3868) Open Access

Disclosure:

The focused issue “The Changing World of Drug Development” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Christian Dittrich served as the unpaid Guest Editor for the focused issue.